Your browser doesn't support javascript.
loading
Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma.
Gartrell, Robyn D; Marks, Douglas K; Rizk, Emanuelle M; Bogardus, Margaret; Gérard, Camille L; Barker, Luke W; Fu, Yichun; Esancy, Camden L; Li, Gen; Ji, Jiayi; Rui, Shumin; Ernstoff, Marc S; Taback, Bret; Pabla, Sarabjot; Chang, Rui; Lee, Sandra J; Krolewski, John J; Morrison, Carl; Horst, Basil A; Saenger, Yvonne M.
Afiliação
  • Gartrell RD; Columbia University Irving Medical Center, New York, New York.
  • Marks DK; Columbia University Irving Medical Center, New York, New York.
  • Rizk EM; Columbia University Irving Medical Center, New York, New York.
  • Bogardus M; College of Physician and Surgeons, Columbia University, New York, New York.
  • Gérard CL; Lausanne University Hospital, Lausanne, Switzerland.
  • Barker LW; College of Physician and Surgeons, Columbia University, New York, New York.
  • Fu Y; College of Physician and Surgeons, Columbia University, New York, New York.
  • Esancy CL; Columbia University Irving Medical Center, New York, New York.
  • Li G; Mailman School of Public Health, Columbia University, New York, New York.
  • Ji J; Mailman School of Public Health, Columbia University, New York, New York.
  • Rui S; Mailman School of Public Health, Columbia University, New York, New York.
  • Ernstoff MS; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Taback B; Columbia University Irving Medical Center, New York, New York.
  • Pabla S; OmniSeq, Inc., Buffalo, New York.
  • Chang R; University of Arizona, Tucson, Arizona.
  • Lee SJ; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Krolewski JJ; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Morrison C; OmniSeq, Inc., Buffalo, New York.
  • Horst BA; University of British Columbia, Vancouver, Canada.
  • Saenger YM; Columbia University Irving Medical Center, New York, New York. yms4@cumc.columbia.edu.
Clin Cancer Res ; 25(8): 2494-2502, 2019 04 15.
Article em En | MEDLINE | ID: mdl-30647081
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Suscetibilidade a Doenças / Imunidade / Melanoma Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Suscetibilidade a Doenças / Imunidade / Melanoma Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article